Non-invasive modulation of meningeal lymphatics ameliorates ageing and Alzheimer's disease-associated pathology and cognition in mice

Miao Wang,Congcong Yan,Xi Li,Tianhao Yang,Shengnan Wu,Qian Liu,Qingming Luo,Feifan Zhou

DOI: https://doi.org/10.1038/s41467-024-45656-7

IF: 16.6

2024-02-18

Nature Communications

Abstract:Meningeal lymphatic vessels (mLVs) have been shown to be involved in amyloid beta (Aβ) clearance, which is considered as a potential therapeutic target for Alzheimer's disease (AD). In this study, based on the superficial spatial distribution of mLVs, a near-infrared light is employed to modulate lymphatic drainage, significantly improving cognition of both aged and AD (5xFAD and APP/PS1) mice, and alleviating AD-associated pathology by reducing Aβ deposition, neuroinflammation and neuronal damage. Furthermore, transmission electron microscopy imaging and RNA sequencing data indicate amelioration of mitochondrial metabolism and cellular junction of meningeal lymphatic endothelial cells (mLECs) by light modulation. These studies collectively suggest that near-infrared light treatment can improve cognitive function by strengthening scavenging ability of mLVs through restoring mLEC function. In conclusion, lymphatic drainage potentiation by light promotes pathological remission and cognitive enhancement in aging and AD mouse models, which offers a potential amelioration strategy for neurodegenerative diseases.

multidisciplinary sciences

What problem does this paper attempt to address?

The paper aims to address the issues of cognitive dysfunction and pathological features associated with neurodegenerative diseases related to meningeal lymphatic vessels (mLVs), particularly Alzheimer's disease (AD). Specifically, the researchers utilized near-infrared light to modulate the function of meningeal lymphatic vessels to improve cognitive abilities and alleviate pathological symptoms in aged mice and Alzheimer's disease mice.

The main findings of the study include:

1. **Cognitive Function Improvement**: Near-infrared light therapy significantly enhanced the cognitive function of aged mice and two Alzheimer's disease model mice (5xFAD and APP/PS1), especially in the novel object recognition test and Y-maze test.
2. **Alleviation of Pathological Features**: Near-infrared light therapy reduced β-amyloid deposition, neuroinflammation, and neuronal damage, thereby improving the pathological conditions of the mice.
3. **Enhancement of mLVs Structure and Function**: Near-infrared light not only enhanced the drainage capacity of meningeal lymphatic vessels but also increased the vascular diameter of mLVs, promoting the recovery of cellular metabolism and cell junction functions.
4. **Mechanism Exploration**: Through gene expression analysis, the study found that near-infrared light therapy might improve the pathological state of AD mice by regulating the expression of genes related to neuroprotection and inflammatory responses.

In summary, this study proposes a potential strategy for improving Alzheimer's disease and related neurodegenerative diseases using non-invasive near-infrared light therapy.